Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Benign Neoplasms

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czoli, CD; Hammond, D1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Benign Neoplasms

ArticleYear
Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007-2009 through 2012-2013.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged; Biomarkers; Canada; Carcinogens; Child; Child, Preschool; Cross-Sectional Studies; Environmental Monitoring; Female; Health Surveys; Humans; Male; Middle Aged; Neoplasms; Nitrosamines; Prevalence; Smoking; Tobacco Products; Young Adult

2018